SAR448501
DR-0201-ONC-001
Phase 1 small_molecule active
Quick answer
SAR448501 for B-cell Non Hodgkin Lymphoma is a Phase 1 program (small_molecule) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pasteur
- Indication
- B-cell Non Hodgkin Lymphoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active